menu
    • menu

    Company profile for Lexogen

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by the AVV Investment Group. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien. Lexogen is b...
    Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by the AVV Investment Group. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien. Lexogen is based at the Vienna BioCenter in Vienna, Austria, and has a subsidiary in New Hampshire, USA. 50% of Lexogen employees work in R&D.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LexogenAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Campus Vienna Biocenter 5 1030 Vienna
    Telephone
    Telephone
    +43 (0) 1 345 1212
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexogen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lexogen-gmbh
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lexogen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexogen Completes Human Primary Cell Sequencing Project
    Lexogen Completes Human Primary Cell Sequencing Project

    25 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lexogen-successfully-completes-large-scale-human-primary-cell-next-gen-sequencing-project-with-ochre-bio-302624463.html

    PR NEWSWIRE
    25 Nov 2025
    Share Share
    Lexogen honored as one of Austria's Top Innovative Companies 2026
    Lexogen honored as one of Austria's Top Innovative Companies 2026

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lexogen-honored-as-one-of-austrias-top-innovative-companies-2026-by-statista-and-trend-magazine-302610386.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Lexogen Launches miRVEL Kit for Cost-Efficient RNA Profiling
    Lexogen Launches miRVEL Kit for Cost-Efficient RNA Profiling

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lexogen-launches-mirvel-profiling-small-rna-seq-kit-for-streamlined-and-cost-efficient-srna-expression-analysis-302583561.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
    Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963284/0/en/Cytosurge-and-Lexogen-Partner-to-Advance-Live-Cell-Sequencing.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Lexogen launches end-to-end solutions for FFPE Transcriptomics
    Lexogen launches end-to-end solutions for FFPE Transcriptomics

    10 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lexogen-launches-end-to-end-solutions-for-ffpe-transcriptomics-302111816.html

    PR NEWSWIRE
    10 Apr 2024
    Share Share
    Singular Genomics Partners with Lexogen to Enable RNA Library Prep
    Singular Genomics Partners with Lexogen to Enable RNA Library Prep

    10 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/10/2363867/0/en/Singular-Genomics-Partners-with-Lexogen-to-Enable-RNA-Library-Prep-for-the-G4-Sequencing-Platform.html

    GLOBENEWSWIRE
    10 Jan 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search